Merck & Co., Inc. (MRK) stock
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30240% above fair value
$143.37−1.09 (-0.75%)
Close on Nov 17, 2026Market cap $353.72BP/E 114.7Yield 2.29%
Merck price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Merck's price to book ratio was 8.8× on Nov 10, 2026, against 5.1× a year earlier. Over the last 5 years it ranged from 4.0× to 8.9×, with a median of 5.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 10, 2026 | 8.8× | +3.6 |
| 2025 | Dec 31, 2025 | 5.1× | −0.6 |
| 2024 | Dec 31, 2024 | 5.7× | −1.0 |
| 2023 | Dec 29, 2023 | 6.7× | +0.4 |
| 2022 | Dec 30, 2022 | 6.3× | +0.9 |
| 2021 | Dec 31, 2021 | 5.4× | −1.7 |
| 2020 | Dec 31, 2020 | 7.1× | −1.7 |
| 2019 | Dec 31, 2019 | 8.8× | +2.4 |
| 2018 | Dec 31, 2018 | 6.4× | +2.3 |
| 2017 | Dec 29, 2017 | 4.1× | +0.3 |
| 2016 | Dec 30, 2016 | 3.8× | +0.4 |
| 2015 | Dec 31, 2015 | 3.3× | −0.4 |
| 2014 | Dec 31, 2014 | 3.8× | +0.6 |
| 2013 | Dec 31, 2013 | 3.2× | +1.0 |
| 2012 | Dec 31, 2012 | 2.3× | +0.4 |
| 2011 | Jan 31, 2011 | 1.8× | −0.2 |
| 2010 | Dec 31, 2010 | 2.0× | – |
See a number that looks wrong?